Breaking News

Clorox Narrows First-Quarter View

October 31, 2005

Clorox Co. cut its earnings forecast for the current fiscal year due to rising energy-related costs driven by recent hurricanes. The Oakland-based maker of bleach and other household products also plans price increases on about 40% of its products.
Clorox lowered forecast for earnings from continuing operations for the fiscal year that ends in June to between $2.91 and $3.06 a share. It had earlier expected earnings of $3 to $3.11 a share.
However, Clorox raised its forecast for the fiscal first quarter ended Sept. 30. It now expects to report income of 68-to 72 cents a share from continuing operations. It previously expected earnings of 65-72 cents a share. The company said it cut the forecast due to higher commodity costs.
  • Patent Activity: Colgate-Palmolive

    Patent Activity: Colgate-Palmolive

    December 6, 2016
    New oral care compositions, the use of radish root ferment filtrate in a cleanser and more.

  • Sparkle & Shine

    Sparkle & Shine

    Melissa Meisel, Associate Editor||November 21, 2016
    Glam packaging and upscale scent combos are big at Yankee Candle for Holiday 2016.

  • Cos Bar: Turning 40 and Hitting Fast Forward

    Cos Bar: Turning 40 and Hitting Fast Forward

    Christine Esposito, Associate Editor||November 21, 2016
    With a recent investor infusion, a new CEO and rebranding effort underway, this luxury beauty retailer has big plans.

  • Slow & Steady

    Slow & Steady

    Tom Branna, Editorial Director||December 1, 2016
    In a tumultuous environment, steady gains posted in the industrial and institutional cleaning sector are welcomed.

  • The World Comes to Orlando

    The World Comes to Orlando

    Tom Branna, Editorial Director||December 1, 2016
    More than 1,600 chemists traveled to Florida for the IFSCC Congress

  • The Plex  Phenomenon

    The Plex Phenomenon

    Denise Costrini, Croda North America||December 1, 2016
    Croda details the hair-protecting qualities of bond multipliers and the company’s new bond-building formulation system.